Literature DB >> 9649939

Genetic risk factors for myocardial infarction.

A J Marian1.   

Abstract

Myocardial infarction (MI) is a complex phenotype caused by interaction of a number of genetic and environmental factors. A genetic susceptibility to MI was observed in a familial aggregation and studies in twins. Advances in molecular genetics have led to identification of a number of potential genetic risk factors for MI, such as variants of genes involved in vascular homeostasis, thrombosis, and lipid metabolism. Functional variants of angiotensin-1-converting enzyme (ACE), beta-fibrinogen, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase, glycoprotein Illa, and many apolipoprotein genes are considered excellent candidate risk factors for MI. Interaction of the susceptibility genes with modifier genes, environmental factors, and conventional risk factors results in the final phenotype of MI. Understanding the complex interaction between these factors is expected to provide significant insights into the pathogenesis of MI and lead to development of genetic-based risk stratification, prevention, and treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649939

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  3 in total

1.  Correlations of SELE and SELP genetic polymorphisms with myocardial infarction risk: a meta-analysis and meta-regression.

Authors:  Yu-Juan Zhao; Xia Yang; Li Ren; An-Sheng Cai; Yan-Fen Zhang
Journal:  Mol Biol Rep       Date:  2014-03-18       Impact factor: 2.316

2.  Commentary: Why are children in the same family so different? Non-shared environment three decades later.

Authors:  Robert Plomin
Journal:  Int J Epidemiol       Date:  2011-06       Impact factor: 7.196

3.  Lack of association between a functional variant of the BRCA-1 related associated protein (BRAP) gene and ischemic stroke.

Authors:  Yi-Chu Liao; Hsiu-Fen Lin; Yuh-Cherng Guo; Chung-Hung Chen; Zhi-Zhang Huang; Suh-Hang Hank Juo; Ruey-Tay Lin
Journal:  BMC Med Genet       Date:  2013-01-28       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.